Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
61.65
-1.68 (-2.65%)
At close: Oct 6, 2026, 4:00 PM EDT
61.13
-0.52 (-0.84%)
Pre-market: Oct 7, 2026, 5:17 AM EDT
Disc Medicine Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Disc Medicine stock has a consensus rating of "Strong Buy" and an average price target of $103.17. The average 1-year stock price forecast is 67.35% higher than the current stock price, while the lowest is $83 (+34.63%) and the highest is $128 (+107.62%).
Price Target: $103.17 (+67.35%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Disc Medicine stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +94.65% | Sep 22, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 21, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $79 → $86 | Buy | Reiterates | $79 → $86 | +39.50% | Sep 16, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $100 | Buy | Maintains | $100 | +62.21% | Sep 11, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $100 | Buy | Reiterates | $100 | +62.21% | Sep 10, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
34.89M
EPS This Year
-6.56
from -6.01
EPS Next Year
-7.08
from -6.56
EPS and Forward PE are based on non-GAAP adjusted numbers.